07/02/2015 - New CF Therapy approved by FDA
The FDA approved Orkambi for people with CF ages 12 and older who have two copies of the F508del mutation. Nearly half of individuals with CF read more...
05/05/2015 - State Newborn Screening Rises to 31 conditions:
Newborn Screening in Arkansas increased to 29 metabolic conditions with the implementation of screening for Severe Combined Immunodeficiency read more...